Market by Cellulite Type, Procedure Type, End-user, and Country Outlook | Forecast 2023-2030
As per Triton’s research report, the cellulite treatment market in Europe is estimated to advance with a compound annual growth rate of 9.51% during the forecast years 2023-2030.
Report scope can be customized per your requirements - Request Free Sample Report
The countries reviewed in the region consist of:
•
United Kingdom
•
Germany
•
France
•
Spain
•
Italy
• Nordic
Countries
•
Rest of Europe
In
Europe, the rising adoption of advanced technologies and new product launches
are expected to elevate the demand for cellulite treatments. Along with this, the
rising preference for non-invasive and minimally invasive procedures as well as
high obesity rates, are anticipated to raise the demand for cellulite
procedures. Further, several leading companies like Sinclair have expanded operations
in the region, which also adds to the cellulite treatment market’s expansion.
The United Kingdom captures the
highest share in the cellulite treatment market. Estimates indicate that about
25.3% of adults were diagnosed with obesity between 2020 and 2021. The obesity
level is expected to rise further over the forecast period. Additionally, there
is a rise in the aging population, which has increased the demand for various
aesthetic procedures. Therefore, the high prevalence of obesity and an aging
population are expected to widen the scope of the studied market.
On
the other hand, Germany witnessed a significant rise in cosmetic procedures in
2021. As per estimates, there were around 1,550 plastic surgeons in 2021. The
growing number of aesthetic treatments and high availability of plastic
surgeons are anticipated to drive the cellulite treatment market’s expansion in
the upcoming years.
Soft
cellulite, also known as flaccid cellulite, refers to skin sagginess around
arms, thighs, buttocks, and hips. Treatments like radiofrequency have proven
effective in areas with more fat accumulation. Lack of physical activity and
unhealthy diet often results in this type’s formation. The market’s segmentation is based on cellulite type, end-user, and
procedure type. The cellulite type is sectioned into soft, hard, and
edematous cellulite.
The prominent companies listed in
the given market include Johnson & Johnson, AbbVie Inc, Bausch Health
Companies Inc, Cutera Inc, and Inceler Medikal.
Johnson
& Johnson is engaged in manufacturing and selling a wide range of products
in the healthcare industry. It operates through various business segments,
including consumer health and medical devices. The consumer health segment
includes products for skin health, baby care, etc. The company invests
substantially in R&D to deliver innovative products. Johnson &
Johnson’s subsidiaries operate around 85 manufacturing facilities across
multiple regions, including Europe.
Key deliverables of the report:
· Market CAGR during the forecasting
years 2023-2030
· Detailed data highlighting key
insights, industry components, and market strategies
· Comprehensive information and
estimation of the cellulite treatment market revenue growth in Europe and its
influence on the parent market
· In-depth study of forthcoming trends
in consumer behavioral patterns
· A meticulous analysis of the
competitive landscape, vendor scorecard, and Porter’s Five Forces
· A wide-ranging study of factors that
will challenge the Europe cellulite treatment market’s growth during the
upcoming years
Want
to get specific insights? Our team of analysts can customize this report based
on your preferences. Connect with us here.
Market By Category, Applicatio ..
VIEW REPORT
Market by RTD Type | Forecast ..
VIEW REPORT
Market by Product Type | Forec ..
VIEW REPORT
Market by Product, Application ..
VIEW REPORT
Market By Product Type, Specie ..
VIEW REPORT
Market by Ingredient Type, Age ..
VIEW REPORT
Market By Demographics, Produc ..
VIEW REPORT
Market by Type, Sales Channel, ..
VIEW REPORT1. EUROPE
CELLULITE TREATMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1.PARENT
MARKET ANALYSIS
2.2.IMPACT
ANALYSIS ON THE CELLULITE TREATMENT MARKET
2.2.1.COVID-19
IMPACT ON THE CELLULITE TREATMENT MARKET
2.2.2.UKRAINE-RUSSIA
WAR IMPACT ON THE CELLULITE TREATMENT MARKET
2.3.PORTER’S
FIVE FORCES ANALYSIS
2.3.1.THREAT
OF NEW ENTRANTS
2.3.2.THREAT
OF SUBSTITUTES
2.3.3.BARGAINING
POWER OF BUYERS
2.3.4.BARGAINING
POWER OF SUPPLIERS
2.3.5.THREAT
OF COMPETITIVE RIVALRY
2.4.MARKET
MATURITY ANALYSIS
2.5.INDUSTRY
COMPONENTS
2.5.1.RESEARCH
AND DEVELOPMENT
2.5.2.MANUFACTURING
OF PRODUCT
2.5.3.DISTRIBUTION
2.5.4.POST-SALES
MONITORING
2.6.REGULATORY
FRAMEWORK
2.7.KEY
BUYING IMPACT ANALYSIS
2.7.1.PRICE
2.7.2.BRAND
NAME
2.7.3.USABILITY
2.8.KEY
MARKET STRATEGIES
2.8.1.COLLABORATIONS
2.8.2.PRODUCT
LAUNCHES
2.8.3.MERGERS
& ACQUISITIONS
2.8.4.BUSINESS
DIVESTITURES & EXPANSIONS
2.9.MARKET
DRIVERS
2.9.1.GROWING
PREVALENCE OF OBESITY
2.9.2.RAPIDLY
GROWING MEDICAL TOURISM SECTOR
2.9.3.RISING
DEMAND FOR AESTHETIC PROCEDURES
2.10.MARKET
CHALLENGES
2.10.1.LACK
OF KNOWLEDGE REGARDING CELLULITE TREATMENT
2.10.2.HIGH
PRICE OF ADVANCED CELLULITE TREATMENT
2.10.3.RISKS
ASSOCIATED POST-TREATMENT
2.11.MARKET
OPPORTUNITIES
2.11.1.RISING
BEAUTY CONSCIOUSNESS
2.11.2.INCREASING
TREND OF ANTI-CELLULITE MASSAGE
2.11.3.GROWING
DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
2.11.4.RISING
POPULARITY OF RADIOFREQUENCY THERAPY FOR CELLULITE TREATMENT
2.11.5.ADVANCEMENTS
IN TECHNOLOGIES AND NEW PRODUCT LAUNCHES
2.12.ANALYST
PERSPECTIVE
3. EUROPE
CELLULITE TREATMENT MARKET – BY CELLULITE TYPE
3.1.SOFT
CELLULITE
3.2.HARD
CELLULITE
3.3.EDEMATOUS
CELLULITE
4. EUROPE
CELLULITE TREATMENT MARKET – BY PROCEDURE TYPE
4.1.NON-INVASIVE
4.2.MINIMALLY
INVASIVE
4.3.TOPICAL
5. EUROPE
CELLULITE TREATMENT MARKET – BY END-USER
5.1.HOSPITALS
5.2.CLINICS
AND BEAUTY CENTERS
5.3.OTHER
END-USERS
6. EUROPE
CELLULITE TREATMENT MARKET – BY COUNTRY OUTLOOK
6.1.COUNTRY
ANALYSIS
6.1.1.UNITED
KINGDOM
6.1.1.1.UNITED
KINGDOM CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.2.GERMANY
6.1.2.1.GERMANY
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.3.FRANCE
6.1.3.1.FRANCE
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.4.ITALY
6.1.4.1.ITALY
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.5.SPAIN
6.1.5.1.SPAIN
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.6.NORDIC
COUNTRIES
6.1.6.1.NORDIC
COUNTRIES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.7.REST
OF EUROPE
6.1.7.1.REST
OF EUROPE CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
7. COMPETITIVE
LANDSCAPE
7.1.JOHNSON
& JOHNSON
7.1.1.OVERVIEW
7.1.2.PRODUCT
PORTFOLIO
7.1.3.KEY
STRENGTHS
7.1.4.KEY
CHALLENGES
7.2.ABBVIE
INC
7.2.1.OVERVIEW
7.2.2.PRODUCT
PORTFOLIO
7.2.3.KEY
STRENGTHS
7.2.4.KEY
CHALLENGES
7.3.BAUSCH
HEALTH COMPANIES INC
7.3.1.OVERVIEW
7.3.2.PRODUCT
PORTFOLIO
7.3.3.KEY
STRENGTHS
7.3.4.KEY
CHALLENGES
7.4.CUTERA
INC
7.4.1.OVERVIEW
7.4.2.PRODUCT
PORTFOLIO
7.4.3.KEY
STRENGTHS
7.4.4.KEY
CHALLENGES
7.5.INCELER
MEDIKAL
7.5.1.OVERVIEW
7.5.2.PRODUCT
PORTFOLIO
7.5.3.KEY
STRENGTHS
7.5.4.KEY
CHALLENGES
7.6.ZIMMER
MEDIZINSYSTEME GMBH
7.6.1.OVERVIEW
7.6.2.PRODUCT
PORTFOLIO
7.6.3.KEY
STRENGTHS
7.6.4.KEY
CHALLENGES
7.7.GALDERMA
SA
7.7.1.OVERVIEW
7.7.2.PRODUCT
PORTFOLIO
7.7.3.KEY
STRENGTHS
7.7.4.KEY
CHALLENGES
7.8.SIENTRA
INC
7.8.1.OVERVIEW
7.8.2.PRODUCT
PORTFOLIO
7.8.3.KEY
STRENGTHS
7.8.4.KEY
CHALLENGES
7.9.ENDO
INTERNATIONAL PLC
7.9.1.OVERVIEW
7.9.2.PRODUCT
PORTFOLIO
7.9.3.KEY
STRENGTHS
7.9.4.KEY
CHALLENGES
7.10.CANDELA
MEDICAL CORPORATION
7.10.1.OVERVIEW
7.10.2.PRODUCT
PORTFOLIO
7.10.3.KEY
STRENGTHS
7.10.4.KEY
CHALLENGES
8. RESEARCH
METHODOLOGY & SCOPE
8.1.RESEARCH
SCOPE & DELIVERABLES
8.1.1.OBJECTIVES
OF STUDY
8.1.2.SCOPE
OF STUDY
8.2.SOURCES
OF DATA
8.2.1.PRIMARY
DATA SOURCES
8.2.2.SECONDARY
DATA SOURCES
8.3.RESEARCH
METHODOLOGY
8.3.1.EVALUATION
OF THE PROPOSED MARKET
8.3.2.IDENTIFICATION
OF DATA SOURCES
8.3.3.ASSESSMENT
OF MARKET DETERMINANTS
8.3.4.DATA
COLLECTION
8.3.5.DATA
VALIDATION & ANALYSIS
TABLE 1: EUROPE CELLULITE
TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY
FRAMEWORK
TABLE 3: LIST OF
COLLABORATIONS
TABLE 4: LIST OF
PRODUCT LAUNCHES
TABLE 5: LIST OF
MERGERS & ACQUISITIONS
TABLE 6: LIST OF
BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: EUROPE
CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: EUROPE
CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: EUROPE
CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: EUROPE
CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
FIGURE 1: MARKET
MATURITY ANALYSIS
FIGURE 2: INDUSTRY
COMPONENTS
FIGURE 3: KEY BUYING
IMPACT ANALYSIS
FIGURE 4: EUROPE
CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2022 & 2030 (IN %)
FIGURE 5: EUROPE
CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 6: EUROPE
CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 7: EUROPE CELLULITE
TREATMENT MARKET, BY PROCEDURE TYPE, 2022 & 2030 (IN %)
FIGURE 8: EUROPE
CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 9: EUROPE
CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 10: EUROPE
CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2030 (IN $ MILLION)
FIGURE 11: EUROPE
CELLULITE TREATMENT MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 12: EUROPE
CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 13: EUROPE CELLULITE
TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2030 (IN $ MILLION)
FIGURE 14: EUROPE
CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)
FIGURE 15: EUROPE
CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 16: UNITED
KINGDOM CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: GERMANY
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: FRANCE
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 19: ITALY
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 20: SPAIN
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 21: NORDIC
COUNTRIES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 22: REST OF
EUROPE CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)